Merck (MRK) Reports In-Line Q4; Guides In-Line
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $126.94 --0%
EPS Growth %: +37.9%
Financial Fact:
Other (income) expense, net: -3.28B
Today's EPS Names:
SFST, VLTO, CLIR, More
EPS Growth %: +37.9%
Financial Fact:
Other (income) expense, net: -3.28B
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q4 EPS of $0.89, versus the consensus of $0.89. Revenue for the quarter came in at $10.1 billion, versus $10.22 billion consensus.
GUIDANCE:
Merck sees FY2017 EPS of $3.72-$3.87, versus the consensus of $3.85.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novartis (NVS) Tops Q1 EPS by 13c, raises guidance
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Medpace Holdings (MEDP) Tops Q1 EPS by 72c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
